Insider Selling: HCA Healthcare Inc (HCA) Insider Sells 4,943 Shares of Stock

HCA Healthcare Inc (NYSE:HCA) insider Michael S. Cuffe sold 4,943 shares of HCA Healthcare stock in a transaction that occurred on Friday, November 9th. The stock was sold at an average price of $141.90, for a total value of $701,411.70. Following the transaction, the insider now owns 33,240 shares in the company, valued at approximately $4,716,756. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link.

Michael S. Cuffe also recently made the following trade(s):

  • On Friday, November 2nd, Michael S. Cuffe sold 5,196 shares of HCA Healthcare stock. The stock was sold at an average price of $136.52, for a total value of $709,357.92.

NYSE:HCA traded up $2.32 on Friday, reaching $143.95. The company’s stock had a trading volume of 1,903,245 shares, compared to its average volume of 1,943,778. HCA Healthcare Inc has a 12-month low of $74.26 and a 12-month high of $144.18. The company has a market capitalization of $46.80 billion, a P/E ratio of 21.84, a P/E/G ratio of 1.19 and a beta of 0.48.

HCA Healthcare (NYSE:HCA) last posted its earnings results on Tuesday, October 30th. The company reported $2.16 EPS for the quarter, beating the Zacks’ consensus estimate of $1.93 by $0.23. HCA Healthcare had a negative return on equity of 73.71% and a net margin of 6.82%. The company had revenue of $11.45 billion for the quarter, compared to the consensus estimate of $11.29 billion. During the same quarter in the previous year, the business earned $1.13 earnings per share. The company’s revenue for the quarter was up 7.1% on a year-over-year basis. Equities analysts expect that HCA Healthcare Inc will post 9.35 EPS for the current year.

The company also recently disclosed a quarterly dividend, which will be paid on Friday, December 28th. Stockholders of record on Monday, December 3rd will be paid a $0.35 dividend. The ex-dividend date is Friday, November 30th. This represents a $1.40 dividend on an annualized basis and a dividend yield of 0.97%. HCA Healthcare’s payout ratio is presently 21.24%.

Hedge funds and other institutional investors have recently modified their holdings of the company. Smithfield Trust Co. grew its stake in shares of HCA Healthcare by 541.9% in the second quarter. Smithfield Trust Co. now owns 995 shares of the company’s stock valued at $102,000 after buying an additional 840 shares in the last quarter. Signet Financial Management LLC acquired a new position in HCA Healthcare during the 2nd quarter worth $137,000. Peak Asset Management LLC acquired a new position in HCA Healthcare during the 3rd quarter worth $212,000. Private Advisor Group LLC acquired a new position in HCA Healthcare during the 3rd quarter worth $212,000. Finally, Adviser Investments LLC acquired a new position in HCA Healthcare during the 2nd quarter worth $159,000. 70.84% of the stock is owned by institutional investors and hedge funds.

A number of equities analysts recently commented on HCA shares. Credit Suisse Group lifted their price objective on HCA Healthcare from $156.00 to $165.00 and gave the stock an “outperform” rating in a research report on Thursday, November 1st. Jefferies Financial Group lifted their price objective on HCA Healthcare to $155.00 and gave the stock a “buy” rating in a research report on Friday, September 21st. SunTrust Banks lifted their price objective on HCA Healthcare to $150.00 and gave the stock a “positive” rating in a research report on Tuesday, September 4th. Morgan Stanley lifted their price objective on HCA Healthcare from $115.00 to $124.00 and gave the stock an “underweight” rating in a research report on Wednesday, September 5th. Finally, Cantor Fitzgerald reiterated a “buy” rating and set a $115.00 price objective on shares of HCA Healthcare in a research report on Friday, July 20th. Two investment analysts have rated the stock with a sell rating, four have assigned a hold rating and sixteen have given a buy rating to the company. HCA Healthcare has a consensus rating of “Buy” and a consensus price target of $141.53.

TRADEMARK VIOLATION NOTICE: This story was first published by American Banking News and is the property of of American Banking News. If you are accessing this story on another publication, it was stolen and reposted in violation of international copyright & trademark laws. The correct version of this story can be viewed at https://www.americanbankingnews.com/2018/11/09/insider-selling-hca-healthcare-inc-hca-insider-sells-4943-shares-of-stock.html.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, provides health care services. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy services.

See Also: What is a Reverse Stock Split?

Insider Buying and Selling by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply